The validity of animal models of predisposition to depression

Behavioural Pharmacology

Volumn 13, Issue 3, 2002, Pages 169-188

  Willner, P ^a   Mitchell, P J ^a  

^a University of Bath   (United Kingdom)

Author keywords

Animal models; Depression; Developmental models; Dysthymia; Genetic models; Genomic models; Lesion models; Predisposition; Validity

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; NEUROKININ 1 RECEPTOR; SEROTONIN;

ANIMAL BEHAVIOR; ANIMAL MODEL; BRAIN INJURY; DEPRESSION; DISEASE PREDISPOSITION; DYSTHYMIA; GENETIC MODEL; GENOMICS; NONHUMAN; REVIEW; SCORING SYSTEM; SEROTONINERGIC SYSTEM; STRESS; VALIDATION PROCESS;

EID: 0036328118     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200205000-00001     Document Type: Review

References (185)

1. Modeling psychopathology in the laboratory: History and rationale
2. Learned helplessness in humans: Critique and reformulation
3. Hopelessness depression: A theory-based subtype of depression
4. Dysthymic disorder: Psychopathology of proposed chronic depressive subtypes
5. Interaction of biologic and psychologic factors in the origin of depressive disorders
6. A developmental perspective on recurrent mood disorders: A review of studies in man
7. The nosological status of neurotic depression: A prospective three- to four-year follow-up examination in light of the primary-secondary and unipolar-bipolar dichotomies
8. Action of antidepressant drugs on maternal stress-induced hypoactivity in female rats
9. Behavioral despair in mice after prenatal stress
10. Faster response on amisulpride 50 mg versus sertraline 50-100 mg in patients with dysthymia or double depression: A randomised, double-blind, parallel group study
11. Stress and depression: A test of the buffering model of social support
12. Deficits of escape performance following catecholamine depletion: Implications for behavioural deficits induced by uncontrollable stress
13. Attenuation of hypercortisolemia in fawn-hooded rats by antidepressant drugs
14. Functional and biochemical evidence for altered serotonergic function in the fawn-hooded rat strain
15. Long-term antidepressant treatment restores clomidine's effect on growth hormone secretion in a genetic animal model of depression
16. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress
17. Modulation of glucocorticoid receptor gene expression by antidepressant drugs
18. Regulation of corticosteroid receptor gene expression in depression and antidepressant action
19. Behavioural characterization of a transgenic mouse model of impaired type II glucocorticoid receptor function
20. The effects of chronic antidepressant treatment in an animal model of anxiety
21. Is the forced swimming test a suitable model for revealing antidepressant activity?
22. BIMT 17: A putative antidepressant with a fast onset of action?
23. Atypical antipsychotic drugs in dysthymia: Placebo controlled studies of amisulpride versus imipramine versus amineptine
24. Serotonin-mimetic and antidepressant drugs on passive avoidance learning by olfactory bulbectomized rats
25. Corticosterone, choline acetyltransferase and noradrenaline levels in olfactory bulbectomized rats in relation to changes in passive avoidance acquisition and open field activity
26. A psychosocial view of depression
27. Evidence for a serotonergic mechanism of the learned helplessness phenomenon
28. Behandlung reactiver depressionen mit sulpirid. Doppelblindstudie mit sulprid und amitriptylin im interindividuellen vergleich
29. Olfactory projection systems, drugs and behaviour: A review
30. The dexamethasone suppression test for melancholia
31. Effects of piracetam on learned helplessness in rats
32. The effect of different serotonergic drugs in the learned helplessness model of depression
33. Prenatal stress has long-term effects on behavioral responses to stress in juvenile rhesus monkeys
34. Reduced anxiety-like and cognitive performance in mice lacking the corticotropin-releasing factor receptor 1
35. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors - Implications for the pathophysiology of mood and anxiety disorders
36. Combining pindolol and paroxetine in an animal model of chronic antidepressant action - Can early onset of action be detected?
37. 1A antagonist, WAY-100635, alone, and in combination with paroxetine, on olfactory bulbectomy and 8-OH-DPAT-induced changes in the rat
38. Behavioural changes after acute and chronic administration of typical and atypical antidepressants in rat: Interactions with reserpine
39. The efficacy of drug treatments for dysthymia: A systematic review and meta-analysis
40. Clinical evidence for a role of dopaminergic systems in depressive syndromes
41. Long-term effects of inescapable stress on daily running activity and antagonism by desipramine
42. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants
43. Reciprocal suppression of regional cerebral blood flow during emotional versus higher cognitive processes: Implications for interactions between emotion and cognition
44. Neurochemical and behavioral consequences of mild uncontrollable shock: Effects of PCPA
45. Effects of bilateral arenalectomy on the induction of learned helplessness behavior
46. Possible antidepressant effects of opioids: Action of buprenorphine
47. Inbred Roman high- and low-avoidance rats: Differences in anxiety, novelty-seeking, and shuttlebox behaviors
48. 1B receptors in knock-out mice lacking the 5-HT transporter
49. Regional serotonin metabolism under basal and restraint stress conditions in the brain of transgenic mice with impaired glucocorticoid receptor function
50. Major depressive disorder
51. Effects of acute and chronic anti-panic drug administration on conflict behavior in the rat
52. Neonatal treatments with the serotonin uptake inhibitors clomipramine and zimelidine, but not the noradrenaline uptake inhibitor desipramine, disrupt sleep patterns in adult rats
53. Alterations in monoamine-containing neuronal function due to administration of anti-depressants repeatedly to rats
54. 5-Hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in P (neurokinin 1) receptor knock-out mice mimic antidepressant desensitization
55. Efficacy of an Hypericum perforatum (St John's wort) extract in preventing and reverting a condition of escape deficit in rats
56. Animal models of psychiatric disorders
57. 1A agonists
58. Long-term interference effect: An alternative to 'learned helplessness'
59. Abnormalities of hypothalamic-pituitary-adrenal and hypothalamic-somatotrophic axes in Fawn-Hooded rats
60. Dexamethasone suppression test in helpless rats
61. The effects of social isolation on the forced swim test in Fawn hooded and Wistar rats
62. Effects of isolation-rearing on voluntary consumption of ethanol, sucrose and saccharin solutions in Fawn Hooded and Wistar rats
63. Differential basis of strain and rearing effects on open-field behaviour in Fawn Hooded and Wistar rats
64. Neonatal administration of the selective serotonin reuptake inhibitor Lu 10-134-C increases forced swimming-induced immobility in adult rats: A putative animal model of depression?
65. Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression
66. Animal models in the study of the genetic factors in human psychopathology
67. Increased adult behavioural 'despair' in rats neonatally exposed to desipramine or zimelidine: An animal model of depression
68. Stress, hypercortisolism and corticosteroid receptors in depression: Implications for therapy
69. Effects of signaling inescapable shock on subsequent escape learning: Implications for theories of coping and 'learned helplessness'
70. Exposure to inescapable shock produces both activity and associative deficits in rats
71. Effects of antidepressant drugs on the behavior of olfactory bulbectomized and sham-operated rats
72. The effects of fluoxetine and zimelidine on the behavior of olfactory bulbectomized rats
73. High social anxiety and low aggression in Fawn-Hooded rats
74. 1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment
75. The olfactory bulbectomized rat as a model of depression: An update
76. The effects of stressful life events on depression
77. Early stress and genetic influences on hypothalamic-pituitary-adrenal axis functioning in adulthood
78. Genetic predisposition and the development of posttraumatic stress disorder in an animal model
79. Distinct mechanism for antidepressant activity by blockade of central substance P receptors
80. Anti-stress activity of Indian Hypericum perforatum L.
81. The use of the sleep laboratory in the diagnosis of affective disorders
82. Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation
83. Fawn-hooded rats show enhanced active behaviour in the forced swimming test, with no evidence for pituitary-adrenal axis hyperactivity
84. 5-HT-HPA interactions in two models of transgenic mice relevant to major depression
85. Pharmacological interventions in dysthymia
86. Amisulpride versus imipramine and placebo in dysthymia and major depression
87. The olfactory bulbectomized rat as a model of depression
88. The immune system, depression and the action of antidepressants
89. Opioid and non-opioid mechanisms of stress-induced analgesia
90. 1A binding sites in 5-HT transporter knockout mice
91. 1A) in 5-HT transporter knock-out mice: Gender and brain region differences
92. Glucocorticoid receptor impairment alters CNS re-sponses to a psychological stressor: An in vivo microdialysis study in transgenic mice
93. Life events and depressive disorder reviewed
94. The action of monoaminergic, cholinergic and gabaergic compounds in the olfactory bulbectomized rat model of depression
95. Olfactory bulbectomy as a model for agitated hyposerotonergic depression
96. Reduction of intraspecific aggression in adult rats by neonatal treatment with a selective serotonin reuptake inhibitor
97. Antidepressants preferentially enhance habituation to novelty in the olfactory bulbectomized rat
98. Shuttle-box deficits induced by inescapable shocks in rats: Reversal by the beta-adreno-receptor stimulants clenbuterol and salbutamol
99. Reversal of helpless behaviour by serotonin reuptake inhibitors
100. Sucrose consumption as a hedonic measure following chronic unpredictable mild stress
101. Reciprocal limbic-cortical function and negative mood: Converging PET findings in depression and normal sadness
102. The effect of venlafaxine treatment on the behavioural and neurochemical changes in the olfactory bulbectomised rat
103. (+)-S-20499 - A potential antidepressant? A behavioural and neurochemical investigation in the olfactory bulbectomised rat
104. Behavioural and physiological consequences of a single social defeat in Roman high- and low-avoidance rats
105. Effects of task-irrelevant cues and reinforcement delay on choice-escape learning following inescapable shock: Evidence for a deficit in selective attention
106. Uncontrollable shock, forebrain norepinephrine, and stimulus selection during choice-escape learning
107. Long-term antidepressant treatment reduces behavioural deficits in transgenic mice with impaired glucocorticoid receptor function
108. Antidepressant treatment prevents chronic unpredictable mild stress-induced anhedonia as assessed by ventral tegmental self-stimulation behavior in rats
109. Rewarding effects of opiates are absent in mice lacking the receptor for substance P.
110. Suppression of sucrose drinking by chronic mild unpredictable stress: A methodological analysis
111. The symptoms of major depression
112. Antidepressant drugs normalize the increased social behaviour of pairs of male rats induced by short term isolation
113. Amisulpride: A review of its clinical potential in dysthymia
114. Treatment of major depression with metyrapone and hydrocortisone
115. Escapability and generalization: Effect on behavioural despair
116. A behavioral, psychopharmacological and neurochemical update on the Flinders Sensitive Line rat, a potential genetic animal model of depression
117. The Flinders sensitive line rats: A genetic animal model of depression
118. A cholinergic supersensitivity model of depression
119. Genetic animal models of depression and ethanol preference provide support for cholinetrgic and serotonergic involvement in depression and alcoholism
120. Administration of antidepressants, diazepam and psychomotor stimulants further confirms the utility of Flinders Sensitive Line rats as an animal model of depression
121. Physiology and pharmacology of corticotropin-releasing factor
122. Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity
123. Antidepressant-like activity of amisulpride in two animal models of depression
124. Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene
125. Antidepressant drug action in a transgenic mouse model of endocrine changes seen in depression
126. Behavioural despair
127. Depression: A new animal model sensitive to antidepressant treatment
128. Immobility induced by forced swimming in rats: Effects of agents which modify central catecholamine and serotonin activity
129. Pharmacological models of depression
130. Decreased hyperthermic effect of MK-801 in selectively bred hypercholinergic rats
131. Chronic mild stress-induced anhedonia: Greater effect in a genetic rat model of depression
132. Dopaminergic hypothesis of retarded depression: A symptom profile for predicting therapeutical responses
133. 2A receptors in mice lacking the serotonin transporter
134. Responses of young children to separation from their mothers
135. 1) receptors attenuates neonatal vocalization in guinea-pigs and mice
136. Comparison of the phenotype of NK1R-/- mice with pharmacological blockade of the substance P (NK1) receptor in assays for antidepressant and anxiolytic drugs
137. Animal models in biological psychiatry
138. Immobility-reducing effects of antidepressants in a genetic animal model of depression
139. Stressor-provoked behavioral changes in six strains of mice
140. Specificity of the learned helplessnes model of depression
141. Congenital helpless rats as a genetic model for cortex metabolism in depression
142. Corticotropin releasing factor receptor-1-deficient mice display decreased anxiety, impaired stress response, and aberrant neuroendocrine development
143. The use of Schneider's typology for the diagnosis of personality disorder: An examination of reliability
144. Gender and gonadal hormone effects in the olfactory bulbectomized animal model of depression
145. The genetic epidemiology of major depression: Review and meta-analysis
146. Prenatal stress alters brain catecholaminergic activity and potentiates stress-induced behavior in adult rats
147. + treatment prevents behavioral depression in rats
148. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor
149. Antidepressant effects of nicotine in an animal model of depression
150. Depressive characteristics of FSL rats: Involvement of central nicotinic receptors
151. Effects of psychotropic drugs on the behaviour and neurochemistry of olfactory, bulbectomized rats
152. Neonatal treatment with clomipramine increased immobility in the forced swim test: An attribute of animal models of depression
153. Behavioral effects of neonatal treatment with clomipramine, scopolamine, and idazoxan in male rats
154. Pharmacology of dysthymia: Review and new findings
155. A new animal model of endogenous depression: A summary of present findings
156. Dose-dependent decrements in adult male rat sexual behavior after neonatal clorimipramine treatment
157. Learned helplessness in the rat: Improvements in validity and reliability
158. Effects of prenatal stress on defensive withdrawal behavior and corticotropin releasing factor systems in rat brain
159. Animal models of depression and schizophrenia
160. A model for neurochemical study of depression
161. The differential effects of prenatal stress in rats on the acoustic startle reflex under baseline conditions and in response to anxiogenic drugs
162. The validity of animal models of depression
163. Validating criteria for animal models of human mental disorders: Learned helplessness as a paradigm case
164. Sensitization to the actions of antidepressant drugs
165. Towards a theory of serotonergic dysfunction in depression
166. Animal models of depression: An overview
167. Behavioural models in psychopharmacology
168. Animal models as simulations of depression
169. Validity, reliability and utility of the chronic mild stress (CMS) model of depression: A ten-year review and evaluation
170. Animal models of depression: A diathesis-stress approach
171. Reduction of sucrose preference by chronic mild unpredictable stress, and its restoration by a tricyclic antidepressant
172. Stress-induced changes in daily activity in the rat are modulated by different factors than are stress-induced escape-learning deficits
173. Stressor-provoked alterations of intracranial self-stimulation in the mesocortiolimbic dopamine system: An animal model of depression
174. Region-specific reductions of intracranial self-stimulation after uncontrollable stress: Possible effects on reward processes
175. Strain specific effects of inescapable shock on intracranial self-stimulation from the nucleus accumbens